ASHLEE CAPPONI: Open Payments
NPI 1205373560 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 87 payments from 16 companies in 2025. Trend: 2023 $312 · 2024 $1,647 · 2025 $1,885
Food & beverage: $1,800Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $348 |
| Janssen Biotech, Inc. | 8 | $338 |
| PFIZER INC. | 22 | $322 |
| Madrigal Pharmaceuticals | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $137 |
| Ardelyx, Inc. | 5 | $104 |
| Lilly USA, LLC | 5 | $97 |
| GENZYME CORPORATION | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Novo Nordisk Inc | 2 | $53 |
Products named: TREMFYA, XELJANZ, VELSIPITY, DUPIXENT, REZDIFFRA, RINVOQ, ENTYVIO, IBSRELA.
Industry payments across NC — which companies pay providers there.
